Back

Comparative effectiveness of GDMT in the prevention of HF morbidity and death among patients with HFrEF in a U.S. database

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Epidemiology and outcomes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speakers

Photo
Doctor Lori D Bash

Merck & Co., Inc., Rahway (United States of America)

Photo
Doctor Andra Stevenson

Chatham (United States of America)

7 More presentations in this session

Presentation thumbnail
Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum
Doctor G. Heitzinger (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
The prognostic association of atrial fibrillation on heart failure hospitalizations after acute myocardial infarction
Doctor A. Achanta (Boston, US)
Abstract Slides Video
Presentation thumbnail
Incorporating hypochloremia provides additive prognostic information in hospitalized patients with heart failure
Doctor K. Misumi (Fukuoka, JP)
Abstract Slides Video
Presentation thumbnail
Change in incidence of ischemic stroke and mortality among patients with atrial fibrillation over a period of 30 years, a nationwide, register-based cohort study
Doctor C. Basic (Gothenburg, SE)
Abstract Slides Video
Presentation thumbnail
Long-term prognostic significance modified body mass index in patients with decompensated acute heart failure: Insight from the OPAR study
Doctor Y. Chang (Osaka, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Epidemiology and outcomes

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources